NYSE : HIMS
Hims & Hers Health, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 29.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.92B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 6.48B |
| Enterprise Value | 7.18B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 224.94M |
| Shares Outstanding | 233.31M |
| Shares Change (YoY) | -7.33% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 8.36% |
| Owned by Institutions (%) | 67.06% |
| Float | 213.76M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 80.34 |
| PS Ratio | 2.50 |
| Forward PS | 1.75 |
| PB Ratio | 19.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 77.78 |
| P/OCF Ratio | 24.51 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 86.28 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.93 |
| Quick Ratio | 0.82 |
| Debt / Equity | 4.77 |
| Debt / EBITDA | 171.37 |
| Debt / FCF | 18.62 |
| Interest Coverage | -10.44 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -32.03% |
| Return on Assets (ROA) | -2.21% |
| Return on Invested Capital (ROIC) | -10.49% |
| Return on Capital Employed (ROCE) | -4.54% |
| Weighted Average Cost of Capital (WACC) | 14.31% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | -$58,161 |
| Employee Count | 2,442 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 6.84 |
Taxes
| Measure | Value |
|---|
| Income Tax | -21.58M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.43 |
| 52-Week Price Change | -39.49% |
| 50-Day Moving Average | 28.91 |
| 200-Day Moving Average | 27.01 |
| Relative Strength Index (RSI) | 44.26 |
| Average Volume (20 Days) | 9,504,992 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 53.47M |
| Short Previous Month | 52.92M |
| Short % of Shares Out | 22.92% |
| Short % of Float | 25.02% |
| Short Ratio (days to cover) | 5.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.58B |
| Gross Profit | 1.79B |
| Operating Income | -97.37M |
| Pretax Income | -163.61M |
| Net Income | -142.03M |
| EBITDA | -10.18M |
| EBIT | -97.37M |
| Loss Per Share | -$0.62 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 841.05M |
| Total Debt | 1.55B |
| Net Cash | -705.19M |
| Net Cash Per Share | -$3.02 |
| Equity (Book Value) | 324.07M |
| Book Value Per Share | 1.39 |
| Working Capital | -98.62M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 263.45M |
| Capital Expenditures | -180.42M |
| Depreciation & Amortization | 87.19M |
| Net Borrowing | 390.43M |
| Free Cash Flow | 83.03M |
| FCF Per Share | $0.36 |
Margins
| Measure | Value |
|---|
| Gross Margin | 69.53% |
| Operating Margin | -3.78% |
| Pretax Margin | -6.35% |
| Profit Margin | -5.51% |
| EBITDA Margin | -0.39% |
| EBIT Margin | -3.78% |
| FCF Margin | 3.22% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.33% |
| Shareholder Yield | 7.33% |
| Earnings Yield | -2.24% |
| FCF Yield | 1.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.15 |
| Price Target Difference | 12.17% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 24.12% |
| EPS Growth Forecast (3Y) | 5.44% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |